Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride, when taken daily, lowers dihydrotestosterone levels but doesn't noticeably affect adrenal steroid production, except by blocking the 5 alpha-reductase enzyme.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

Glucocorticoid and mineralocorticoid therapy effectively manage Congenital Adrenal Hyperplasia symptoms but have limitations.

Abnormal adrenal function is not the cause of alopecia in Pomeranians; it may be due to breed-specific hormones.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

New genes and pathways are important for testosterone production and male sexual development.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

Inhaled substances in e-cigarettes can cause hormone imbalances similar to congenital adrenal hyperplasia.

Pesticides can cause reproductive and adrenal health issues.

Genetic defects in androgen production are linked to male developmental disorders and are improving treatment understanding.

Fetal ovaries produce different hormones than adult ovaries, and endocrine-disrupting chemicals may affect this process.

Congenital Adrenal Hyperplasia is a rare inherited disease causing hormone imbalances, affecting growth, fertility, and heart health, diagnosed through blood tests and treated with medication and lifestyle changes.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Genetic variants in CYP genes may worsen PCOS symptoms.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

A rare case of Cushing syndrome was successfully treated with one-sided adrenal gland removal, suggesting personalized treatment is important.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Testosterone therapy improved symptoms in a woman with congenital adrenal hyperplasia.